IL4I1: An inhibitor of the CD8+ antitumor T-cell response in vivo

European Journal of Immunology

Volumn 41, Issue 6, 2011, Pages 1629-1638

  Lasoudris, Fanette ^a,b   Cousin, Céline ^a,b   Prevost Blondel, Armelle ^c   Martin Garcia, Nadine ^a,b   Abd Alsamad, Issam ^d   Ortonne, Nicolas ^a,b,e   Farcet, Jean Pierre ^a,b,e   Castellano, Flavia ^a,b,e   Molinier Frenkel, Valérie ^a,b,e  

^a INSERM U955   (France)

^b CNRS   (France)

^c INSTITUT COCHIN   (France)

^d CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

IL4I1; Immunoediting; Mice; Phenylalanine oxidase; Tumor escape

Indexed keywords

AMINO ACID OXIDASE; CATECHOL OXIDASE; EPITOPE; GAMMA INTERFERON; GP33 ANTIGEN; INTERLEUKIN 4 INDUCED PROTEIN 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; HODGKIN DISEASE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; MELANOMA; MESOTHELIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR ESCAPE; TUMOR GROWTH; TUMOR REJECTION; VACCINATION;

AMINO ACID OXIDOREDUCTASES; ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL GROWTH PROCESSES; GLYCOPROTEINS; HUMANS; HYDROGEN PEROXIDE; IMMUNIZATION; IMMUNOSUPPRESSION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; TRANSGENES; TUMOR ESCAPE; VIRAL PROTEINS;

EID: 79957543400     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041119     Document Type: Article

References (28)

1. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
2. Gordon, S. and Martinez, F. O., Alternative activation of macrophages: mechanism and functions. Immunity 2010. 32: 593-604.
3. Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P. and Bronte, V., Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 2008. 222: 162-179.
4. Nishikawa, H. and Sakaguchi, S., Regulatory T cells in tumor immunity. Int. J. Cancer 2010. 127: 759-767.
5. Youn, J. I. and Gabrilovich, D. I., The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 2010. 40: 2969-2975.
6. Munn, D. H. and Mellor, A. L., Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007. 117: 1147-1154.
7. Munder, M., Arginase: an emerging key player in the mammalian immune system. Br. J. Pharmacol. 2009. 158: 638-651.
8. Bogdan, C., Regulation of lymphocytes by nitric oxide. Methods Mol. Biol. 2011. 677: 375-393.
9. Grohmann, U. and Bronte, V., Control of immune response by amino acid metabolism. Immunol. Rev. 2010. 236: 243-264.
10. Johansson, C. C., Egyhazi, S., Masucci, G., Harlin, H., Mougiakakos, D., Poschke, I., Nilsson, B. et al., Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunol. Immunother. 2009. 58: 1085-1094.
11. Johansson, C. C., Mougiakakos, D., Trocme, E., All-Ericsson, C., Economou, M. A., Larsson, O., Seregard, S. and Kiessling, R., Expression and prognostic significance of iNOS in uveal melanoma. Int. J. Cancer 2010. 126:2682-2689.
12. Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T. and Van den Eynde, B. J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2, 3-dioxygenase. Nat. Med. 2003. 9: 1269-1274.
13. Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A. and Mellor, A. L., Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 1999. 189: 1363-1372.
14. Rodriguez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J., Quiceno, D. G., Ochoa, J. B. and Ochoa, A. C., L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J. Immunol. 2003. 171: 1232-1239.
15. Taheri, F., Ochoa, J. B., Faghiri, Z., Culotta, K., Park, H. J., Lan, M. S., Zea, A. H. and Ochoa, A. C., L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin. Cancer Res. 2001. 7: 958s-965s.
16. Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A. L. et al., Indoleamine 2, 3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer 2002. 101: 151-155.
17. Chu, C. C. and Paul, W. E., Fig1, an interleukin 4-induced mouse B cell gene isolated by cDNA representational difference analysis. Proc. Natl. Acad. Sci. USA 1997. 94: 2507-2512.
18. Boulland, M. L., Marquet, J., Molinier-Frenkel, V., Moller, P., Guiter, C., Lasoudris, F., Copie-Bergman, C. et al., Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood 2007. 110: 220-227.
19. Chavan, S. S., Tian, W., Hsueh, K., Jawaheer, D., Gregersen, P. K. and Chu, C. C., Characterization of the human homolog of the IL-4 induced gene-1 (Fig1). Biochim. Biophys. Acta 2002. 1576: 70-80.
20. Marquet, J., Lasoudris, F., Cousin, C., Puiffe, M., Martin-Garcia, N., Baud, V., Chéreau, F. et al., Dichotomy between factors inducing the immunosuppressive enzyme IL4I1 in B lymphocytes and mononuclear phagocytes. Eur. J. Immunol. 2010. 40:2557-2568.
21. Carbonnelle-Puscian, A., Copie-Bergman, C., Baia, M., Martin-Garcia, N., Allory, Y., Haioun, C., Cremades, A. et al., The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages. Leukemia 2009. 23: 952-960.
22. Prevost-Blondel, A., Zimmermann, C., Stemmer, C., Kulmburg, P., Rosenthal, F. M. and Pircher, H., Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo. J. Immunol. 1998. 161: 2187-2194.
23. Zimmermann, C., Prevost-Blondel, A., Blaser, C. and Pircher, H., Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur. J. Immunol. 1999. 29: 284-290.
24. Roulland, S., Suarez, F., Hermine, O. and Nadel, B., Pathophysiological aspects of memory B-cell development. Trends Immunol. 2008. 29: 25-33.
25. Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H. et al., Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008. 14: 518-527.
26. Janssen, Y. M., Barchowsky, A., Treadwell, M., Driscoll, K. E. and Mossman, B. T., Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 1995. 92: 8458-8462.
27. Kothmaier, H., Quehenberger, F., Halbwedl, I., Morbini, P., Demirag, F., Zeren, H., Comin, C. E. et al., EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors. Thorax 2008. 63: 345-351.
28. Pircher, H., Burki, K., Lang, R., Hengartner, H. and Zinkernagel, R. M., Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989. 342: 559-561.